Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A call for specific geriatric data on cervical cancers.
Rodrigues MJ, Zapardiel I, Frélaut M, Brain E, Falandry C. Rodrigues MJ, et al. Among authors: frelaut m. Future Oncol. 2016 May;12(9):1101-4. doi: 10.2217/fon-2016-0022. Epub 2016 Mar 9. Future Oncol. 2016. PMID: 26955977 No abstract available.
[Immunotherapy in oncology].
Frelaut M, Besse B. Frelaut M, et al. Rev Prat. 2021 Dec;71(10):1051-1056. Rev Prat. 2021. PMID: 35147355 French.
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets.
Moreira A, Masliah-Planchon J, Callens C, Vacher S, Lecerf C, Frelaut M, Borcoman E, Torossian N, Ricci F, Hescot S, Sablin MP, Tresca P, Loirat D, Melaabi S, Trabelsi-Grati O, Pierron G, Gentien D, Bernard V, Vincent Salomon A, Servant N, Bieche I, Le Tourneau C, Kamal M. Moreira A, et al. Among authors: frelaut m. Eur J Cancer. 2019 Nov;121:202-209. doi: 10.1016/j.ejca.2019.09.001. Epub 2019 Oct 5. Eur J Cancer. 2019. PMID: 31593830
Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study.
Gendarme S, Zebachi S, Corre R, Greillier L, Justeau G, Bylicki O, Decroisette C, Auliac JB, Guisier F, Geier M, Ricordel C, Frelaut M, Paillaud E, Chouaïd C, Canouï-Poitrine F. Gendarme S, et al. Among authors: frelaut m. J Geriatr Oncol. 2024 Jul;15(6):101506. doi: 10.1016/j.jgo.2023.101506. Epub 2023 May 19. J Geriatr Oncol. 2024. PMID: 37211514 Free article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 36164053
[No title available]
[No authors listed] [No authors listed] PMID: 36164063
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment.
Couderc AL, Liuu E, Boudou-Rouquette P, Poisson J, Frelaut M, Montégut C, Mebarki S, Geiss R, Ap Thomas Z, Noret A, Pierro M, Baldini C, Paillaud E, Pamoukdjian F. Couderc AL, et al. Among authors: frelaut m. Nutrients. 2023 Feb 27;15(5):1193. doi: 10.3390/nu15051193. Nutrients. 2023. PMID: 36904192 Free PMC article. Review.
28 results